Past Events

October 4, 2018 – Seminar

Corruption and Global Health: A Perspective From Transparency International, UK
Presented by: Sarah Steingrüber, Programme Manager Global Pharmaceuticals & Healthcare Programme Transparency International, London, UK

Thursday, October 4, 2018 at 12:00 PM
Room 850 – Pharmacy Building
144 College Street
Toronto, ON


September 26, 2018 – Seminar

Guest Speaker: Jesse McLean, Toronto Star

Toronto Star investigative reporter Jesse McLean takes us inside his reporting exposing the pharmaceutical industry’s influence on Canadian health care.

Wednesday, September 26, 2018 at 12:00PM
Room 850 – Pharmacy Building
144 College Street
Toronto, ON


January 18, 2018 – WHO Collaborating Centre for Governance, Accountability and Transparency for the Pharmaceutical Sector and Health Law, Ethics & Policy Seminar Series

The Benefit and Risks of Expedited Development and Regulatory Approval of New Drugs
Presented by: Aaron Kesselheim, Associate Professor of Medicine at Harvard Medical School and Director, Program on Regulation, Therapeutics, and Law (PORTAL)

Thursday, January 18, 2018 at 12:30PM
Falconer Hall (Solarium) – University of Toronto
84 Queen’s Park
Toronto, ON

LINK: https://www.law.utoronto.ca/scholarship-publications/workshops-and-seminars/health-law-ethics-and-policy-seminar-series


September 29, 2017 – Workshop

Governance of Pharmaceuticals Policy Workshop

Friday, September 29, 2017 – 9:00AM to 5:00PM
Munk School of Global Affairs – University of Toronto
315 Bloor Street West
Toronto, ON

LINK: Agenda

Corruption, understood as “the misuse of entrusted power for private gain,” is considered to be one of the biggest barriers to human development and economic growth. Corruption is without borders; it can be found in any country, in different forms, levels, and types of organizations and institutions . In the health sector annually, an estimated $5.3 trillion is spent worldwide on providing health services, yet as much as 6 percent or $300 billion USD is lost to corruption and errors according to the World Health Organization. Corruption negatively impacts public health budgets, the price of health services and medicines, and the quality of care and medical products; as well, it threatens a country’s ability to provide universal health coverage by increasing the price of health care. Corruption diverts resources from the public sector, making it difficult to appropriately fund operations and maintenance that help ensure increased access and quality care. The pharmaceutical sector is particularly vulnerable to corruption given it is lucrative, technically complex, and composed of many stakeholders with varying degrees of accountability.

This one day seminar will provide an opportunity for health care professionals and researchers to gain a deeper understanding of how corruption and lack of good governance can have an impact on pharmaceutical services and importantly provide strategies and tactics to educate participants on how to counter vulnerabilities within the sector.

Presentations:


September 28, 2017 – Seminar

Tackling corruption in procurement: how open contracting improved healthcare in Nigeria, Ukraine and Honduras
Presented by: Lucas Amin, Consultant, Transparency International UK

Hosted by:
Dr. Jillian Kohler
T: (416) 946-8708
E: jillian.kohler@utoronto.ca

Thursday, September 28, 2017 at 12:00PM
Room 450 – Pharmacy Building
144 College Street
Toronto, ON

LINK: Poster


June 13, 2017 – Book Launch for Joel Lexchin

Doctors in Denial: Why Big Pharma and the Canadian medical profession are too close for comfort

Tuesday, June 13, 2017 – 7:00PM to 9:00PM
Tranzac Club
292 Brunswick Avenue
Toronto, ON

LINK: More Information


May 23, 2017 – Seminar

Should Canada Develop A List Of Essential Medicines?

Speakers:

Nicola Magrini
Secretary of the Expert Committee on the Selection and Use of Essential Medicines;
Policy, Access and Use Team; Department of Essential Medicines and Health Products
(EMP/PAU); World Health Organization

Lars Gustaffson
Professor, Senior Consultant; Division of Clinical Pharmacology; Department of Laboratory
Medicine; Karolinska Institutet; Karolinska University Hospital

Tuesday, May 23, 2017 – 3:00PM to 5:00PM
Room N108, North House
Munk School of Global Affairs – University of Toronto
1 Devonshire Place
Toronto, Ontario

The World Health Organization recommends that each state define its own list of essential medicines. Essential medicines lists generally contain hundreds of medicines including treatments for acute conditions (e.g. pneumonia, anaphylaxis, sprained ankles) and chronic diseases (e.g. diabetes, HIV-AIDS, hypertension). Lists of essential medicines can help governments ensure adequate healthcare services are delivered by identifying the medications that are needed by people.

More than 100 countries have developed essential medicine lists, Canada is not one of them.

Should Canada develop a list of essential medicines? We will learn from two international experts about the benefits and challenges of creating an essential medicines list: Dr Nicola Magrini from the World Health Organization’s Essential medicines group and Professor Lars Gustaffson from the Swedish “Wise List”. Then we will hear the reactions of Canadian decision makers before we open up the discussion to involve all participants.

This event is supported by the WHO Collaborating Center for Governance, Accountability and Transparency for the Pharmaceutical Sector.

REGISTER: http://munkschool.utoronto.ca/event/23013/

LINK: Poster


February 2, 2017 – WHO Collaborating Centre for Governance, Accountability and Transparency for the Pharmaceutical Sector and Health Law, Ethics & Policy Seminar Series

Access to Medicine – Benchmarking pharmaceutical companies in weak regulatory environments
Presented by: Luca Genovese, Researcher, Access to Medicines Foundation, Netherlands

Hosted by: Dr. Jillian Kohler
T: (416) 946-8708
E: jillian.kohler@utoronto.ca

Thursday, February 2, 2017 at 12:30PM
Falconer Hall (Solarium) – University of Toronto
84 Queen’s Park
Toronto, ON

LINK: Poster


November 28, 2016 – Symposium

Symposium: Combating Corruption in Health Care and Pharmaceuticals

Monday, November 28, 2016 – 9:30AM to 4:30PM
Munk School of Global Affairs, Room N208 – University of Toronto
1 Devonshire Place
Toronto, ON

LINK: Agenda

Speakers:

  • Sidney Wolfe, M.D., Co-founder of Public Citizen’s Health Research Group and long-time defender of patients’ rights. Adjunct Professor, Case Western Reserve University School of Medicine. LINK: https://www.citizen.org/about/sidney-m-wolfe-md
  • Joel Lexchin, M.D., Professor, School of Health Policy and Management, York University.
  • Kiymet Çaliyurt, Professor in the Faculty of Business Administration and Economics, Trakya University, Turkey.
  • James Crombie, Associate Professor of Philosophy, Université Sainte-Anne, Nova Scotia. Adjunct professor in the Dalhousie University Faculty of Health Professions.
  • Marc-André Gagnon, Associate Professor, School of Public Policy and Administration, Carleton University. Visiting Professor at the Ottawa Center for Health Law, Policy and Ethics.
  • Fred Gifford, Center for Ethics and Humanities in the Life Sciences, Michigan State University.
  • Jillian Kohler, Professor, Leslie Dan Faculty of Pharmacy, the Munk School of Global Affairs and the Dalla Lana School of Public Health, University of Toronto. Director of the WHO Collaborating Centre for Governance, Accountability and Transparency in the Pharmaceutical Sector of the University of Toronto.
  • Paul D. Thacker, independent investigative journalist, based in Madrid, specializing in scientific, medical and environmental issues.

Presentations:

LINK: Poster


April 29, 2016 – WHO Collaborating Centre for Governance, Accountability and Transparency Policy Workshop and Launch

Taking the Pulse of Governance, Accountability, and Transparency in the Pharmaceutical Sector: Diagnosing the Issues
Sponsored by: The Leslie Dan Faculty of Pharmacy, Munk School of Global Affairs, and Dalla Lana School of Public Health

Friday, April 29, 2016 – 12:00PM to 3:30PM
Room 850 – Pharmacy Building
144 College Street
Toronto, ON

LINK: Agenda
LINK: WHO CC Launch Overview and Transcript

Presentations:

LINK: Poster


April 28, 2016 – Seminar

Corruption and the Pharmaceutical & Healthcare Sector: Global Policy and Structural Issues
Presented by: James Sale, Programme Manager, Pharmaceuticals & Healthcare Programme Transparency International, UK

Thursday, April 28, 2016 at 11:00AM
Room 450 – Pharmacy Building
144 College Street
Toronto, ON

LINK: Poster